Tailored Genes

Tailored Genes is a biotechnology company focused on the development of next-generation viral vectors for gene therapy, with a specific emphasis on respiratory diseases. The company utilizes a proprietary platform that creates chimeric vectors by combining Adeno-associated virus (AAV) with Human Bocavirus (HBoV), known as BoAAV. This technology is designed to improve the transduction efficiency of the respiratory epithelium, which has historically been a challenge for standard AAV vectors. Their lead research efforts are directed toward treating cystic fibrosis by delivering functional CFTR genes to the lungs. Tailored Genes operates as an R&D-stage entity, leveraging deep expertise in parvovirus biology to expand the reach of genetic medicines.